Clinical trials
Completed Lymphoma, Non-Hodgkin trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
939 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 45 |
| 2001 | 26 |
| 2002 | 38 |
| 2003 | 44 |
| 2004 | 55 |
| 2005 | 46 |
| 2006 | 44 |
| 2007 | 44 |
| 2008 | 43 |
| 2009 | 40 |
| 2010 | 46 |
| 2011 | 43 |
| 2012 | 33 |
| 2013 | 32 |
| 2014 | 27 |
| 2015 | 23 |
| 2016 | 20 |
| 2017 | 34 |
| 2018 | 25 |
| 2019 | 15 |
| 2020 | 20 |
| 2021 | 15 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 939 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 91 |
| Fred Hutchinson Cancer Center | 58 |
| Memorial Sloan Kettering Cancer Center | 42 |
| M.D. Anderson Cancer Center | 40 |
| Case Comprehensive Cancer Center | 24 |
| University of Nebraska | 20 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 17 |
| Celgene | 13 |
| City of Hope Medical Center | 13 |
| Mayo Clinic | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Non-Hodgkin | 939 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 435 |
| Hodgkin Disease | 415 |
| Lymphoma, Follicular | 406 |
| Lymphoma | 400 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 399 |
| Lymphoma, Large B-Cell, Diffuse | 397 |
| Lymphoma, Mantle-Cell | 375 |
| Lymphoma, B-Cell, Marginal Zone | 336 |
| Lymphoma, Large-Cell, Immunoblastic | 320 |
Trials
Showing 1 to 25 of 939. Each trial links to its page on Pharma Observatory.
839 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.